TWA
TMO icon

Tandem Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Tandem Wealth Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$515K Buy
1,048
+92
+10% +$49.9K 0.23% 37
2025
Q4 		$554K Buy
956
+130
+16% +$73.5K 0.25% 33
2025
Q3 		$401K Buy
826
+44
+6% +$20.5K 0.19% 42
2025
Q2 		$317K Buy
782
+145
+23% +$60.6K 0.16% 43
2025
Q1 		$317K Buy
637
+5
+0.8% +$2.71K 0.17% 46
2024
Q4 		$329K Sell
632
-159
-20% -$87.4K 0.17% 44
2024
Q3 		$489K Buy
791
+10
+1% +$5.92K 0.25% 29
2024
Q2 		$432K Hold
781
– – 0.23% 27
2024
Q1 		$454K Sell
781
-14
-2% -$7.86K 0.25% 27
2023
Q4 		$422K Hold
795
– – 0.24% 26
2023
Q3 		$402K Sell
795
-3
-0.4% -$1.6K 0.25% 24
2023
Q2 		$416K Buy
798
+61
+8% +$32.9K 0.25% 22
2023
Q1 		$425K Sell
737
-7
-0.9% -$3.94K 0.26% 23
2022
Q4 		$410K Buy
+744
New +$394K 0.26% 27

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Tandem Wealth Advisors's TMO Position: Q1 2026 in Review

Tandem Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 9.6% in Q1 2026, buying an estimated $49.9K and bringing the position to 1,048 shares worth $515K. The position accounts for 0.23% of the portfolio, ranked #37.

Tandem Wealth Advisors first reported a position in TMO in Q4 2022 and has held it in 14 quarters since. The position peaked at $554K in Q4 2025. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Tandem Wealth Advisors held 1,048 shares of Thermo Fisher Scientific worth $515K as of Q1 2026.
  • Tandem Wealth Advisors bought 92 Thermo Fisher Scientific shares in Q1 2026, an estimated $49.9K.
  • Thermo Fisher Scientific made up 0.23% of Tandem Wealth Advisors's portfolio in Q1 2026, its #37 holding.
  • Tandem Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2022 and has held it in 14 quarters since.
  • Tandem Wealth Advisors's Thermo Fisher Scientific position peaked at $554K in Q4 2025.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Tandem Wealth Advisors's 13F filing for Q1 2026, filed 6 May 2026.